Deletion of Ptpmt1 by αMHC-Cre in Mice Results in Left Ventricular Non-Compaction

Lei Huang, Ming Cao, Xiangbin Zhu, Na Li, Can Huang, Kunfu Ouyang, Ze’e ChenJournal of Developmental Biology 2025 · DOI

TL;DR

This study identifies a critical role for the mitochondrial phosphatase Ptpmt1 in the proper development of the left ventricle in mice. Deleting Ptpmt1 in cardiac cells leads to a severe congenital heart defect called left ventricular non-compaction (LVNC), resulting in perinatal lethality and highlighting Ptpmt1 as a key regulator of heart development.

What Problem Does This Paper Address?

Left ventricular non-compaction cardiomyopathy (LVNC) is a serious congenital heart defect characterized by an abnormally developed left ventricle, featuring an excessively thick, spongy trabecular layer and a thin compacted layer. While known to be a developmental issue, the precise molecular mechanisms driving LVNC, particularly those involving mitochondrial genes, remain poorly understood. This paper aims to elucidate the role of Ptpmt1, a mitochondrial phosphatase gene, in this process, addressing the gap in knowledge regarding its in vivo function during heart development.

Methods

The researchers employed a genetic engineering approach to create a conditional knockout mouse model. They crossed mice with a floxed Ptpmt1 gene (meaning the gene can be selectively deleted) with mice expressing Cre recombinase specifically in cardiomyocytes (heart muscle cells) under the control of the alpha-myosin heavy chain promoter (αMHC-Cre). This generated a cardiomyocyte-specific Ptpmt1 knockout (CKO) mouse.

To assess the impact of Ptpmt1 deletion, a multi-pronged approach was used:

  • Morphological and Histological Analysis: Gross examination of embryos and newborn hearts, along with H&E staining of tissue sections, was performed to visualize structural changes in the ventricular wall, specifically the thickness of the compact and trabecular layers.
  • Immunofluorescence: Staining for cardiomyocyte markers (α-actinin) and nuclei (DAPI) was used to assess cell structure and organization.
  • EdU Incorporation Assay: This technique labels newly synthesized DNA, allowing researchers to quantify cardiomyocyte proliferation in both the compact and trabecular layers.
  • Electrocardiogram (ECG): Recorded to assess cardiac electrical activity and identify potential arrhythmias or functional defects in newborn mice.
  • RNA Sequencing (RNA-seq): Performed on embryonic hearts to generate a comprehensive transcriptional profile and identify differentially expressed genes and affected biological pathways.
  • Quantitative Real-Time PCR (qRT-PCR): Used to validate the expression levels of specific genes identified by RNA-seq.
  • Western Blot Analysis: Employed to measure the protein levels of key signaling molecules involved in stress responses.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Ptpmt1 is essential for left ventricular compaction: The most striking finding is that deleting Ptpmt1 specifically in cardiomyocytes leads to a severe LVNC phenotype, demonstrating its critical role in normal heart development.
  • Mitochondrial stress as a driver of LVNC: The study links Ptpmt1 deficiency to increased levels of phosphorylated eIF2α and ATF4, key indicators of mitochondrial stress. This suggests that impaired mitochondrial function due to Ptpmt1 loss triggers a stress response that disrupts normal cardiac development.
  • Impact on cardiomyocyte proliferation: The reduced proliferation of cardiomyocytes in both the compact and trabecular layers of CKO hearts at E15.5 directly correlates with the observed LVNC phenotype, providing a cellular mechanism for the developmental defect.
  • Dysregulation of key cardiac development genes: RNA-seq analysis revealed significant changes in the expression of genes involved in heart development, cell proliferation, extracellular matrix organization, and cell-cell adhesion, offering a molecular basis for the observed structural abnormalities.

Key Results

  • Perinatal lethality: CKO mice exhibited high perinatal lethality, with approximately 87.5% dying within 24 hours of birth.
  • LVNC phenotype: Newborn CKO mice displayed a clear LVNC phenotype, characterized by a significantly thinner compact zone and a thicker trabecular layer in the left ventricle compared to controls. This phenotype was also observed in embryonic hearts at E15.5 but not at E13.5.
  • Reduced cardiomyocyte proliferation: EdU incorporation assays showed a significant decrease in cardiomyocyte proliferation in CKO hearts at E15.5.
  • Transcriptional changes: RNA-seq identified 886 differentially expressed genes in CKO hearts at E15.5, with significant enrichment in pathways related to heart rate regulation, cell proliferation, and ER stress.
  • Mitochondrial stress markers: Western blot analysis revealed increased levels of phosphorylated eIF2α and ATF4 in CKO hearts, indicating an activated mitochondrial stress response.

Limitations and Future Work

The authors acknowledge several limitations:

  • Focus on embryonic and early postnatal stages: The study primarily examined phenotypes up to postnatal day 1 (P1). They suggest that other conditions, like Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), might emerge later and warrant investigation.
  • Cardiac inflammation: While cardiac inflammation is a known factor in cardiomyopathy, the study did not extensively investigate its role in the Ptpmt1-deficient hearts, though TUNEL staining for cell death was performed.
  • Mechanism of mitochondrial stress: The precise mechanism by which mitochondrial stress triggers the eIF2α/ATF4 pathway in cardiomyocytes remains unclear and is highlighted as an area for future research.

Future work could involve investigating the potential for ARVC in these mice, a more detailed examination of cardiac inflammation and cell death, and a deeper dive into the molecular cascade linking mitochondrial stress to the eIF2α/ATF4 pathway in the context of heart development.

Summary updated

Abstract

<i>Background:</i> Left ventricular non-compaction cardiomyopathy (LVNC) is a congenital heart disease characterized by abnormal prenatal development of the left ventricle that has an aberrantly thick trabecular layer and a thinner compacted myocardial layer. However, the underlying molecular mechanisms of LVNC regulated by mitochondrial phosphatase genes remain largely unresolved. <i>Methods:</i> We generated a mouse model with cardiac-specific deletion (CKO) of <i>Ptpmt1</i>, a type of mitochondrial phosphatase gene, using the <i>αMHC-Cre</i>, and investigated the effects of cardiac-specific <i>Ptpmt1</i> deficiency on cardiac development. Morphological, histological, and immunofluorescent analyses were conducted in <i>Ptpmt1</i> CKO and littermate controls. A transcriptional atlas was identified by RNA sequencing (RNA-seq) analysis. <i>Results:</i> We found that CKO mice were born at the Mendelian ratio with normal body weights. However, most of the CKO mice died within 24 h after birth, developing spontaneous ventricular tachycardia. Morphological and histological analysis further revealed that newborn CKO mice developed an LVNC phenotype, evidenced by a thicker trabecular layer and a thinner myocardium layer, when compared with the littermate control. We then examined the embryonic hearts and found that such an LVNC phenotype could also be observed in CKO hearts at E15.5 but not at E13.5. We also performed the EdU incorporation assay and demonstrated that cardiac cell proliferation in both myocardium and trabecular layers was significantly reduced in CKO hearts at E15.5, which is also consistent with the dysregulation of genes associated with heart development and cardiomyocyte proliferation in CKO hearts at the same stage, as revealed by both the transcriptome analysis and the quantitative real-time PCR. Deletion of <i>Ptpmt1</i> in mouse cardiomyocytes also induced an increase in phosphorylated eIF2α and ATF4 levels, indicating a mitochondrial stress response in CKO hearts. <i>Conclusions:</i> Our results demonstrated that <i>Ptpmt1</i> may play an essential role in regulating left ventricular compaction during mouse heart development.
BibTeX
@article{huang2025deletion,
  author = {Lei Huang and Ming Cao and Xiangbin Zhu and Na Li and Can Huang and Kunfu Ouyang and Ze’e Chen},
  title = {{Deletion of Ptpmt1 by αMHC-Cre in Mice Results in Left Ventricular Non-Compaction}},
  journal = {Journal of Developmental Biology},
  year = {2025},
  doi = {10.3390/jdb13030025},
}
Figure